Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1604497

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1604497

Artificial Intelligence (AI) In Remote Allergy Management Market - Forecasts from 2024 to 2029

PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The Artificial Intelligence (AI) in remote allergy management market is expected to grow at a CAGR of 34.54%, reaching a market size of US$6,965.727 million in 2029 from US$1,580.089 million in 2024.

AI in the remote allergy management market is a cutting-edge and fast-rising industry that uses artificial intelligence (AI) and digital technology to revolutionize allergy monitoring and treatment. People worldwide are being affected by allergies, thus making it necessary to have manageable individualized treatment from a distance. Nowadays, all resources and portable devices allow consumers to effectively control and deal with their allergies without stepping out of the house. These systems incorporate advanced features such as tracking symptoms in real-time, customization of treatment protocols, and video conferencing with doctors.

AI Smarts remote allergic treatments promise to enhance clients' results by improving undesirable patient compliance, providing better patient access to specialized services, and reducing healthcare costs. The growing number of patients enrolling in telemedicine, improving AI algorithms, and increasing demand for effective and proactive management of allergies are the major factors contributing to AI in the remote allergy management market's expansion.

Artificial intelligence (AI) in remote allergy management market drivers:

  • The increasing prevalence of allergies enhances the AI in remote allergy management market growth.

The rising incidence of allergies is a major driver of growth in AI in the remote allergy management market. Allergies affect many individuals worldwide, thus creating a demand for new and better treatment methods. Proponents point to environmental factors, lifestyle changes, and genetic make-up as the key reasons for the increasing number of allergies. Given the increasing prevalence of allergies, there is a burgeoning need for a remote healthcare system able to offer patients with allergies individualized and real-time care. Powered by AI, the platforms are capable of processing big data that include factors such as exposure to allergens, signs and symptoms, and treatment efficacy in enhanced management of allergies, even for patients who are far away.

Artificial Intelligence (AI) in Remote Allergy Management Market Geographical Outlook

  • North America is witnessing exponential growth during the forecast period

North America is at the forefront of embracing novel healthcare technology, such as AI-powered allergy treatment systems. There is a significant frequency of allergies in the region and a great emphasis on expanding telemedicine and digital health platforms.

Furthermore, North America has a strong healthcare infrastructure, a rising number of AI-focused firms, and considerable investment in R&D. The presence of significant players and cooperation between IT businesses and healthcare institutions push AI in remote allergy management market expansion in this area even further. North America continues to lead in revolutionizing allergy management with AI-driven solutions, thanks to technological improvements and rising demand for remote healthcare.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) in remote allergy management market is segmented and analyzed as follows:

By Product Type

  • Mobile Apps
  • Wearable Devices
  • Telemedicine Platforms
  • Others

By Application

  • Allergy Testing and Diagnosis
  • Allergen Immunotherapy Management
  • Symptom Monitoring and Management
  • Medication Management
  • Others

By End-User

  • Hospitals And Clinics
  • Allergy Clinics And Centers
  • Research Institutes
  • Patients (Direct-To-Consumer)
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
Product Code: KSI061615855

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Mobile Apps
  • 5.3. Wearable Devices
  • 5.4. Telemedicine Platforms
  • 5.5. Others

6. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Allergy Testing and Diagnosis
  • 6.3. Allergen Immunotherapy Management
  • 6.4. Symptom Monitoring and Management
  • 6.5. Medication Management
  • 6.6. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals And Clinics
  • 7.3. Allergy Clinics And Centers
  • 7.4. Research Institutes
  • 7.5. Patients (Direct-To-Consumer)
  • 7.6. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. BY End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. BY End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. BY End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. BY End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. BY End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. K Health, Inc.
  • 10.2. Health Navigator
  • 10.3. Buoy Health, Inc.
  • 10.4. Ada Health Gmbh
  • 10.5. Sensely, Inc.
  • 10.6. Your.Md
  • 10.7. Infermedica
  • 10.8. Mediktor, S.L.
  • 10.9. 98point6 Inc.
  • 10.10. Babylon Health
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!